Reviewing the Inability of Anti-Amyloid Immunotherapies to Affect Alzheimer's Disease
A recent Cochrane meta‑analysis of ten anti‑amyloid monoclonal antibodies—including aducanumab, lecanemab and donanemab—shows only trivial cognitive gains and modest functional improvement in patients with mild Alzheimer’s disease, despite clear plaque clearance. The studies also reveal an elevated risk of amyloid‑related imaging abnormalities and inconsistent outcome reporting. These results suggest that amyloid removal alone does not produce meaningful clinical benefits, challenging the long‑standing amyloid cascade hypothesis. Researchers are urged to explore alternative mechanisms such as neuroinflammation or cerebrospinal fluid drainage for disease‑modifying therapies.
New NIHR-Funded TRC for Parkinson’s Disease
The National Institute for Health and Care Research (NIHR) has launched the Parkinson’s disease Translational Research Collaboration (PD‑TRC), the first of eight UK TRCs dedicated to Parkinson’s. Backed by NIHR and four major charities, the hub links 17 centres of...
Lilly Falls on Slower Start for Foundayo versus Wegovy
Eli Lilly’s oral GLP‑1 agonist Foundayo launched in early April with modest uptake, recording 1,390 prescriptions in week 1 and 3,707 in week 2, far below Novo Nordisk’s oral Wegovy, which logged over 3,000 fills in its first days and 18,410 in the second...
Sun Pharma to Acquire Organon for $11.75 B, Boosting Women’s Health and Biosimilars
Sun Pharmaceutical Industries announced an all‑cash deal to acquire Organon & Co. for $14 per share, valuing the U.S. firm at $11.75 billion. The merger will lift Sun Pharma into the top‑25 global drugmakers, give it a top‑3 position in women’s...
UK Biotech Could Be Bound for Recovery, BIA Report Reveals
UK biotech venture financing rebounded in Q1 2026, with total equity raised climbing 18% to £552 m ($746 m). Venture‑capital inflows also rose 17% to £516 m ($699 m), and 25 companies secured funding, up from 15 a year earlier. While public‑market activity stayed flat—no...
New Bird Flu Vaccine Shows Promise Against Multiple H5N1 Strains
University of Nebraska–Lincoln researchers have unveiled a nanodisc‑based vaccine that protects mice and dairy calves from multiple H5N1 bird‑flu strains. The platform uses a prime‑boost regimen combining intramuscular and intranasal delivery to generate systemic and mucosal immunity. Preclinical trials showed...
Precipio (PRPO): Advanced Blood Diagnostics
Precipio (PRPO) showcased its dual‑model strategy in a live MicroCapClub interview, highlighting a low‑cost BCR‑ABL assay developed for under $100,000—far cheaper than the $5‑10 million industry norm. The company reported a 30% revenue increase in 2025, achieving its first profitability inflection...
BrioHealth Secures FDA Approval to Launch BrioVAD System Trial
BrioHealth Solutions received conditional FDA approval to launch the Brio4Kids trial, testing its BrioVAD left ventricular assist device in children with advanced heart failure. Enrollment in the U.S. study is slated for mid‑2026, with initial data expected in the fourth...
Kyowa Kirin and Kura Initiate Phase II Trial of Ziftomenib for AML
Kyowa Kirin and Kura Oncology have opened a Japanese Phase II registrational study of the oral menin inhibitor ziftomenib in adults with relapsed or refractory NPM1‑mutated acute myeloid leukaemia. The single‑arm, open‑label trial will measure a composite complete remission rate (CR + CRh) as...
Review Questions Benefits of Anti-Amyloid Alzheimer’s Drugs
A Cochrane review of 17 clinical trials involving 20,342 patients with early Alzheimer’s disease found that anti‑amyloid drugs provide no clinically meaningful benefit on cognitive decline or dementia severity. The analysis also highlighted an increased risk of brain swelling and...
Sanofi Reports the CHMP Positive Opinion for Cenrifki (Tolebrutinib) to Treat Non-Relapsing SPMS
Sanofi’s oral BTK inhibitor Cenrifki (tolebrutinib) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for treating secondary progressive multiple sclerosis (SPMS) without relapses in the past two years. The recommendation is...
FDA Approves Weekly Self‑Injectable Saphnelo for Lupus
#AZN Saphnelo for treating systemic lupus erythematosus, approved by US FDA for self-administration via a once a week autoinjector Pen.
Understanding How Plants Pause and Restart Growth Can Help Develop Climate‑resilient Crops
Researchers identified the genetic switch that lets plants pause growth during cold, salt or drought stress and resume within roughly 24 hours once conditions improve. Using Arabidopsis roots as a rapid assay, they pinpointed Cyclin‑dependent Kinase A;1 (CDKA;1) as a...
AI in Single-Cell Analysis: Solving the Interpretation Gap
Single‑cell omics drives drug discovery but interpreting cell‑state annotations remains a bottleneck. Nygen Analytics introduced CyteType, an AI‑augmented platform that adds a traceable interpretation layer to existing pipelines, converting raw clusters into biologically meaningful labels. By combining marker‑gene analysis, literature...
Invest in the Future of Cancer Diagnostics and Treatment
Cancer incidence is rising as populations age and obesity increases, prompting a shift toward proactive diagnostics. Researchers are advancing liquid‑biopsy technologies, especially multi‑omics MCED tests, to detect tumors earlier and with greater specificity. Simultaneously, AI‑enhanced imaging is slashing MRI scan...
Exclusive Human Milk Diet Benefits Very Low Birth Weight Infants
A phase III randomized controlled trial in Japan demonstrated that an exclusive human milk diet markedly improves growth velocity and reduces serious complications in very low birth weight (VLBW) infants compared with mixed feeding regimens. The study eliminated bovine‑based protein fortifiers,...
Novartis’ Itvisma Receives the CHMP Positive Opinion for Spinal Muscular Atrophy
Novartis’ gene‑replacement therapy Itvisma (onasemnogene abeparvovec) received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for treating patients aged two years and older with 5q spinal muscular atrophy (SMA). The recommendation is...
Evonik: €80m for Biopharma CDMO Capacity in Slovakia
Evonik Industries is allocating roughly €80 million (about $87 million) to expand its fermentation plant in Slovenská Ľupča, Slovakia. The investment adds downstream capacity for pharmaceutical active ingredients and creates around 50 new jobs. The site, already a biotech hub producing spider‑silk protein...
What Your CD3 T Cell Engager Is Missing
CD3 T‑cell engagers have become a cornerstone of bispecific immunotherapy, linking T cells to cancer cells via the CD3 receptor. The article argues that despite their success, these molecules often provide only the primary activation signal, neglecting a critical secondary...
Turn Health Data Into Impact: Browns University's Online Master in Biostatistics & Health Data Science
Brown University has launched an online Master’s in Biostatistics with a concentration in Health Data Science, delivered through its School of Public Health and School of Professional Studies. The 20‑month, five‑semester program comprises nine courses and a capstone project that...
Swedish Clinic Finds Limited Eligibility for New Alzheimer Drugs
Preparing for the implementation of anti-amyloid therapies in Europe: Assessing real-world eligibility for lecanemab and donanemab in a Swedish memory clinic https://t.co/H3TgYvgVSk
The Cure for Death Means Billionaires Will Live Forever—And Be Rich Forever
U.S. billionaires enjoy a dramatically higher life expectancy, with 20% living past 80 compared to just 3.8% of the general population. Their longevity stems from access to premium healthcare, personal trainers, and cutting‑edge nutrition. Meanwhile, leaders like Putin and Xi...
In the Land of the Unblind: Are Psychedelics Really Better than Antidepressants?
Recent meta‑analysis comparing psychedelic‑assisted therapy (PAT) with open‑label antidepressant trials finds no clinically important difference in depression outcomes. While early PAT studies suggested larger effects, the analysis shows that functional unblinding limits any advantage, and open‑label antidepressants marginally outperform blinded...
Free Radicals Podcast (Longevity / Biotech Oriented)
Kexin Huang, the a16z‑backed founder of Pho, argues that biology is entering an "Agentic Biology" era where AI agents orchestrate research rather than merely analyze data. His Integrated Biology Environment (IBE), embodied in the Biomni platform, acts like an IDE...
Free Radicals Podcast (Longevity / Biotech Oriented)
Nathan Cheng argues that aging remains untreated due to a coordination failure rooted in cultural "deathism," despite roughly 100,000 daily deaths from age‑related diseases. He highlights a stark $5 B versus $100 B+ funding gap between longevity and cancer research, underscoring the...
SAS Forecast Shows AI Shifts to Core Infrastructure in Health and Life Sciences for 2026
SAS’s 2026 outlook declares that data and AI will graduate from experimental projects to essential infrastructure for health care and life sciences. The forecast cites harmonised data streams, quantum‑enabled models and regulatory sandboxes as catalysts for scalable, production‑grade AI deployment.
Secretome-Mediated Antimicrobial and Immunomodulatory Activity of Lactobacillus Johnsonii Against Multidrug-Resistant Enteroaggregative Escherichia Coli
Researchers evaluated Lactobacillus johnsonii as a probiotic against a multidrug‑resistant enteroaggregative E. coli (EAEC) strain. The bacterium showed strong gastrointestinal tolerance, high auto‑aggregation (80 % at 4 h), and secretome‑driven inhibition of EAEC growth and biofilm formation, surpassing gentamicin. It also reduced...
Mapping Genomic Landscape of Multiple Myeloma Precursors
Genomic landscape of multiple myeloma and its precursor conditions [May 21, 2025] Jean-Baptiste Alberge et al. @IrenemGhobrial @NatureGenet https://t.co/DDWGRrpI4Y #mmsm #PrecisionMedicine #cagenome https://t.co/X0OPLHNkdG
Multiple Myeloma Evades GPRC5D T‑Cell Engagers via Multim
Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma [Jan 15, 2026] @hollyleeYJ et al. @NBahlis @NatureMedicine https://t.co/mz393mPMAq #mmsm #PrecisionMedicine #tcellrx THREAD: https://t.co/lNX9b7LsnR HT @AuclairDan https://t.co/d0JNE6pb5x
MIT Unveils Injectable “Mini‑liver” Constructs to Bridge Transplant Waitlist
MIT scientists have engineered injectable hydrogel microsphere “mini‑livers” that sustain liver function in animal models for over two months, aiming to reduce dependence on donor organs. The breakthrough, published in Cell Biomaterials, could reshape treatment for thousands on transplant waiting...
Uridine Shields Neurons by Activating Mitochondrial K⁺ Channel
The Protective Effect of Uridine in a Rotenone-Induced Model of Parkinson’s Disease: The Role of the Mitochondrial ATP-Dependent Potassium Channel https://t.co/jBlSlgedWo
FDA Approves Sanofi's Tzield to Delay Type 1 Diabetes in Children as Young as One Year
Sanofi’s teplizumab‑mzwv, sold as Tzield, received FDA approval to expand its use to children from age one, aiming to postpone the onset of stage 3 type 1 diabetes. The decision follows the PETITE‑T1D phase‑4 trial, which showed 89.6% of participants remained free...
Astrocytic Connexin 43 Hemichannel Dysregulation Drives Prefrontal Circuit Dysfunction and Schizophrenia-Like Behaviors
Researchers found that connexin 43 (Cx43) protein is significantly elevated in the prefrontal cortex of individuals with schizophrenia and in mice treated with the NMDA‑antagonist MK801. The increase is selective for Cx43 and boosts astrocytic hemichannel opening without altering gap‑junction coupling,...
Deregulation Accelerates AI Drug Discovery Across Borders
Two articles were just published in English featuring Insilico and my OpenClaw noticed. Here is an interesting story. In 2017, before going into China, we set up Insilico Korea and I spent a considerable amount of time there trying to...
Probiotics Extend Life of Apparel and Footwear
The Lab, a biotech fashion‑care brand, launched the "Take Care of the Things You Love" campaign to promote probiotic‑based cleaning products that protect and extend the life of sneakers, hats, apparel, denim and accessories. The range uses beneficial bacteria to...
Eli Lilly and Company (LLY): Among the Best Stocks to Buy While the Market Is Down
Eli Lilly announced a strategic acquisition of Kelonia Therapeutics for up to $7 billion, with $3.25 billion paid upfront and up to $3.75 billion in milestones. Kelonia’s in‑body CAR‑T platform, led by Phase 1 candidate KLN‑1010, expands Lilly’s oncology pipeline beyond its dominant weight‑loss franchise....
Blocking Gut “Signal Two” Expands Tregs, Curbs IBD
Blocking immune 'signal two' in the gut expands a specialized regulatory T cell population, suppressing intestinal inflammation and suggesting a new therapeutic approach for inflammatory bowel disease and related autoimmune conditions. immunology
Cornell Researchers Show Stem‑Cell Vesicles Halt Cellular Aging in Lab
Researchers at Cornell University's College of Veterinary Medicine have shown that extracellular vesicles derived from embryonic stem cells can completely halt cellular senescence in cultured cells. The finding opens a new molecular pathway for anti‑aging interventions that biohackers and biotech...
FDA Greenlights First Ibogaine Derivative Trial and Fast‑tracks Three Psychedelics
The U.S. Food and Drug Administration approved the inaugural human study of noribogaine, an ibogaine metabolite, for alcohol‑use disorder and awarded priority‑review vouchers to three psychedelic candidates targeting depression and PTSD. The actions follow President Donald Trump's executive order to...
Toronto Patient Achieves Sustained HIV Remission After Bone Marrow Transplant
Clinicians at University Health Network, Unity Health Toronto and the University of Toronto reported that a 27‑year‑long HIV patient entered sustained remission after a bone‑marrow transplant using a donor with a rare HIV‑resistant mutation. The case, presented at the Canadian...
FDA Grants Priority Review to Ifinatamab Deruxtecan for Treated Small Cell Lung Cancer
The U.S. Food and Drug Administration has placed the B7‑H3‑directed antibody‑drug conjugate ifinatamab deruxtecan, co‑developed by Daiichi Sankyo and Merck, under priority review for patients with previously treated extensive‑stage small cell lung cancer. The agency set a Prescription Drug User...
NTLA Set to Unveil First In‑Vivo CRISPR Phase 3 Data
Here is a video of me entering my office tomorrow knowing that $NTLA is about to present the first-ever Phase 3 data of an In Vivo (!) CRISPR Gene Editing Program. Somehow - and after @adamfeuerstein’s🧵👇- I have a feeling...
Epigenetic Clocks Predict Lung Cancer Risk Beyond Self‑reports
New paper: Epigenetic age clocks help predict lung cancer risk & mortality by estimating smoke exposure. Is independent of self-reported smoking history, so people probably lie about it. Clocks could help doctors predict lung cancer risk & decide on...
Rapid Nanofiber Spinning Fills the Gap in Small-Diameter Vascular Grafts
Researchers at Harvard have demonstrated a focused rotary jet spinning (FRJS) process that fabricates custom small‑diameter vascular grafts in minutes. The technique produces nanofiber scaffolds with tunable architecture, achieving 0.5 mm inner‑diameter tubes in under 90 seconds and larger 10 mm grafts...
AI's First Real Test: Designing Drugs at Isomorphic Labs
Isomorphic Labs Is About to Find Out If AI Can Actually Design a Drug https://t.co/vhQTwhIO85
MIB‑626 NMN Shows Lifespan Boost and New Mechanism
1. No living forever 🙈 2. Some MIB-626 (crystaline polymorph, pure NMN) human clinical trial results are in 😀 3. About to resubmit a revised mouse MIB-626 paper with Alice Kane, showing improved health measures + lifespan & a putative new mechanism...
StockWatch: Trump Order Lifts Psychedelic Drug Shares
President Donald Trump signed Executive Order 14401, directing the FDA to accelerate research and grant Commissioner’s National Priority Vouchers (CNPVs) to breakthrough psychedelic therapies. The order also mandates the HHS to allocate at least $50 million through ARPA‑H to partner with...
Novartis Antimalarial Clears Key WHO Review to Get the Combo Drug to Babies
Novartis’s Coartem Baby, the first antimalarial specifically designed for infants, has cleared the World Health Organization’s pre‑qualification review, allowing public‑sector and donor agencies to procure the drug in regions lacking robust regulatory systems. The formulation, a liquid‑dissolvable, cherry‑flavored version of artemether‑lumefantrine,...
Team Finds Surprising Food Source for Tumors
University of Rochester researchers discovered that cancer cells, particularly breast tumors, consume the antioxidant glutathione as a primary fuel source. Analysis of tumor fluid revealed abundant glutathione, and preclinical experiments showed that inhibiting its uptake slows tumor growth. The team...
Creative Biolabs Launches Integrated Microfluidic Platform for Neuron‑on‑a‑Chip and Cell Sorting
Creative Biolabs announced a new one‑stop microfluidic platform that merges neuron‑on‑a‑chip technology with cell‑sorting chips. The integrated service is designed to cut reagent waste, automate assays and deliver more physiologically relevant data for drug discovery, disease modeling and precision diagnostics.